2005
DOI: 10.1111/j.1445-5994.2004.00764.x
|View full text |Cite
|
Sign up to set email alerts
|

Adult‐onset inflammatory myopathy: North Canterbury experience 1989–2001

Abstract: Inflammatory myopathy is a challenging condition in both diagnosis and management. Our audit has shown delays in the diagnosis of IBM, a relatively high incidence of malignancy and a notable risk of relapse and mortality.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
39
0
1

Year Published

2008
2008
2021
2021

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 40 publications
(42 citation statements)
references
References 19 publications
(26 reference statements)
0
39
0
1
Order By: Relevance
“…Therefore, the probability estimation of the muscles involvements mentioned above is meaningful to diagnose. Lynn et al [13] reported that bulbar muscle was more probably to be involved in sIBMs than in other inflammatory myopathies. Felice and his colleagues [11] reported that 38-84% sIBM patients suffered from bulbar muscle.…”
Section: Discussionmentioning
confidence: 98%
“…Therefore, the probability estimation of the muscles involvements mentioned above is meaningful to diagnose. Lynn et al [13] reported that bulbar muscle was more probably to be involved in sIBMs than in other inflammatory myopathies. Felice and his colleagues [11] reported that 38-84% sIBM patients suffered from bulbar muscle.…”
Section: Discussionmentioning
confidence: 98%
“…Given that autoimmune myopathies affect demographic subgroups differentially, an overall population prevalence estimate might be somewhat uninformative. Variations in the frequency of autoimmune myopathies by age and sex have been estimated in earlier studies 10 11. However, much of the existing data was generated decades ago; the ageing of populations in the developed world probably means that current prevalence is higher than previous estimates 12.…”
Section: Discussionmentioning
confidence: 99%
“…[3][4][5][6] Although immunosuppressive therapies may provide transient benefits, there is no known effective treatment for this condition. 7,8 Dysphagia is more common in IBM than in the other inflammatory myopathies 9 and is reported to be occurring in 38 -84% of patients. 2,3,10 -13 Moreover, its outcome is worse in patients with IBM than in those with either poly-or dermatomyositis 14 and its contribution to aspiration pneumonia associated respiratory failure may be the most common cause of death in people with IBM.…”
mentioning
confidence: 99%